Author Correction: A µ-opioid receptor superagonist analgesic with minimal adverse effects

Biobehavioral Imaging and Molecular Neuropsychopharmacology Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA Juan L. Gomez, Emilya N. Ventriglia, Zachary J. Frangos, Reece C. Budinich, Oscar Solis, Anna E. Tischer, William Dunne, Ingrid Schoenborn & Michael Michaelides Drug Design and Synthesis Section, Molecular Targets and Medication Discovery Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA Agnieszka Sulima & Kenner C. Rice Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA Michael J. Robertson, Michael D. Sacco, Angelina A. Mullarkey, Dain R. Brademan, Ruth Hüttenhain & Georgios Skiniotis Department of Structural Biology, Stanford University School of Medicine, Stanford, CA, USA Michael J. Robertson, Michael D. Sacco & Georgios Skiniotis Department of Pharmacology, Physiology and Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA Ilinca M. Giosan, Tongzhen Xie & Venetia Zachariou Neurobiology of Relapse Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA Jennifer M. Bossert, Kiera E. Caldwell, Hannah Bonbrest & Yavin Shaham Departament de Patologia i Terapèutica Experimental, Institut de Neurociències, Universitat de Barcelona, L’Hospitalet de Llobregat, Spain Amelie Essmann, Zelai M. …